medline.ch Onkologie

	Cancer genome standards for long-read sequencing using cancer cell line mixtures. Gigascience Zhang J, Wong HY, Liu L, Koufariotis LT, Wood S, Fitzpatrick N, Quiatchon J, Collins P, Pearson JV, Waddell N. PMID: 41934171 [PubMed - as supplied by publisher]
	Protocol flexibility in PCOS: a combination of controlled ovarian stimulation and endometrial preparation strategies shows no impact on live birth outcomes after frozen embryo transfer-a retrospective cohort study. Gynecol Endocrinol Chen D, Chen MH, Wang ZY, Luo L, Xu Y, Zhang D. PMID: 41934169 [PubMed - indexed for MEDLINE]
	Drug-related problems among pediatric patients with cancer admitted to the pediatric haemato-oncology department: A prospective observational study. J Oncol Pharm Pract Pathak N, Basyal B, Dhungana S, Sah AK, Shrestha R, Shrestha S, Pandit A, Kunwor P, Karki R. PMID: 41934159 [PubMed - as supplied by publisher]
	Harnessing Isorhamnetin for Gastrointestinal Cancers: Molecular Mechanisms and Therapeutic Potential. J Biochem Mol Toxicol Koli D, Sheokand A, Sharma G, Tuli HS, Pahwa R. PMID: 41934157 [PubMed - indexed for MEDLINE]
	The Impact of Socioeconomic Factors and Racial Disparities on Complications in Breast Conservation Surgery: A Single-Institution Retrospective Cohort Study. Breast J Obaid LN, Zhang JS, Lee GY, Bhimani F, Jao SL, Rachofsky C, Coe LG, Cavalli A, Ki M, Lin J, Gupta A, Feldman S, McEvoy M. PMID: 41934150 [PubMed - indexed for MEDLINE]
	Diarrhea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study. Rheumatology (Oxford) Flatman LK, Beauchamp ME, St-Pierre Y, Malhamé I, Bérard A, Bernatsky S, Vinet É. PMID: 41934107 [PubMed - as supplied by publisher]
	Evaluating the diagnostic efficacy of a 4-marker serum panel for hepatitis B virus-related hepatocellular carcinoma. Lab Med Fang Q, Zhu Y, Liang Y, Li H, Yan S. PMID: 41934102 [PubMed - indexed for MEDLINE]
	Trained immunity responses across infectious diseases and cancer vaccines. Trends Immunol Fu K, Zhang R, Wang Y, Yin R, Yang L. PMID: 41934079 [PubMed - as supplied by publisher]
	Toward mutational epidemiology: using mutational signatures of environmental exposures to assess cancer risk. Trends Cancer Sherman F, Rozowsky JS, Okafor A, Petljak M. PMID: 41934048 [PubMed - as supplied by publisher]
	Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations. Eur Urol Cheng L, Iczkowski KA, van Leenders GJLH, Downes MR, Raspollini MR, Williamson SR, Moch H, Bremmer F, Tickoo SK, Menon S, Cubilla AL, Kristiansen G, Members of ISUP GU Cancer Precursor Consensus Panel. PMID: 41934039 [PubMed - as supplied by publisher]
	Re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette-GuÃ©rin-naÃ¯ve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol Li D. PMID: 41934038 [PubMed - as supplied by publisher]
	Re: Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial. Eur Urol Zhou J, Liu P. PMID: 41934037 [PubMed - as supplied by publisher]
	Real-World Survival Outcomes and Prognostic Factors in De Novo Stage IV Urothelial Bladder Cancer: A 13-Year Retrospective Cohort Study. Clin Genitourin Cancer Mushtaq A, Zabor EC, Adcock B, Dhakal A, Rehman N, Alsabbagh Alchirazi M, Albliwi M, Zureigat H, Lee M, Hassan ANM, Batah H, Patel P, Patel M, Haddad SF, Vincek N, Mustafa Ali MK. PMID: 41934031 [PubMed - as supplied by publisher]
	Adequate Bacillus Calmette-GuÃ©rin maintenance therapy improves recurrence-free survival in high-risk non-muscle-invasive bladder cancer: A conditional survival study. Urol Oncol Bando Y, Teishima J, Tobe T, Ueki H, Wakita N, Okamura Y, Suzuki K, Hara T, Terakawa T, Chiba K, Miyake H. PMID: 41934023 [PubMed - as supplied by publisher]
	Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study. Urol Oncol Zaurito P, Scilipoti P, Longoni M, de Angelis M, , Viti A, Santangelo A, Tremolada G, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M, European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. PMID: 41934021 [PubMed - as supplied by publisher]
	Factors influencing quality of life over five years post-diagnosis in breast cancer survivors: Results from the E3N-Generations cohort. Bull Cancer Paunescu AC, Préau M, Delpierre C, Pannard M, Kvaskoff M. PMID: 41933962 [PubMed - as supplied by publisher]
	[Role of a National Multidisciplinary Tumor Board in the diagnostic and therapeutic management of patients with cancers of unknown primary (CUP)]. Bull Cancer Jacquin N, Nevière Z, Nedara K, Dupain C, Kubicek P, Watson S. PMID: 41933961 [PubMed - as supplied by publisher]
	Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends Endocrinol Metab Costamagna A, Milan G, De Santis MC, Carrer A, Martini M. PMID: 41933959 [PubMed - as supplied by publisher]
	Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer. Adv Sci (Weinh) Liu H, Yuan M, Shang Y, Chen J, Hou F, Wang L, Jiang W. PMID: 41933924 [PubMed - as supplied by publisher]
	The Benefits of Community-Level Efforts to Increase Tree Shade Availability for Cancer Prevention and Control. Public Health Rep Holman DM, Mallen ES, Reza A, Townsend JS, Kava CM. PMID: 41933898 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1924179

Seite 1 von 96209

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung